Yasmin Schmid is a physician specializing in general medicine, clinical pharmacology, and toxicology. She is currently working as a senior physician at the Department of Clinical Pharmacology and Toxicology at the University Hospital Basel, where she has also been a member of Matthias Liechti's psychopharmacology research group for several years. She has been involved in the conduct of several placebo-controlled, double-blind, cross-over studies investigating the effects of various psychoactive substances, including MDMA, LSD, and mescaline, in healthy subjects. Currently, her research focuses on the potential therapeutic applications of LSD, and she is conducting clinical studies involving patients with cluster headaches and patients in palliative care in collaboration with the respective specialists.